Crinetics Pharmaceuticals In shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Crinetics Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Crinetics Pharmaceuticals In held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crinetics Pharmaceuticals In by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $403k | 7.9k | 51.10 |
2024-06-30 | $341k | 7.6k | 44.79 |
2024-03-31 | $316k | 6.8k | 46.81 |
2023-12-31 | $241k | 6.8k | 35.58 |
2023-09-30 | $193k | 6.5k | 29.74 |
2023-06-30 | $72k | 4.0k | 18.02 |
2023-03-31 | $64k | 4.0k | 16.06 |
2022-12-31 | $79k | 4.0k | 19.90 |
2022-09-30 | $78k | 4.0k | 19.56 |
2022-06-30 | $74k | 4.0k | 18.56 |
2022-03-31 | $78k | 3.6k | 21.90 |
2021-12-31 | $101k | 3.6k | 28.35 |
2021-09-30 | $60k | 2.9k | 20.98 |
2021-06-30 | $54k | 2.9k | 18.88 |
2021-03-31 | $37k | 2.4k | 15.48 |
2020-12-31 | $34k | 2.4k | 14.23 |
2020-09-30 | $37k | 2.4k | 15.48 |
2020-06-30 | $42k | 2.4k | 17.57 |
2020-03-31 | $14k | 952 | 14.71 |
2019-12-31 | $24k | 952 | 25.21 |
2019-09-30 | $14k | 952 | 14.71 |
2019-06-30 | $24k | 952 | 25.21 |
2019-03-31 | $13k | 574 | 22.65 |
2018-12-31 | $17k | 574 | 29.62 |
2018-09-30 | $16k | 574 | 27.87 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors